Article

Toric IOL viable option for keratoconus

Emerging experience suggests the boundaries for toric IOL implantation can be expanded to include carefully selected eyes with keratoconus, said Alejandro Navas, MD, MSc.

Chicago-Emerging experience suggests the boundaries for toric IOL implantation can be expanded to include carefully selected eyes with keratoconus, said Alejandro Navas, MD, MSc.

“While there are limited studies that have evaluated toric IOLs for keratoconus, the short term results are promising,” said Dr. Navas, associate professor of ophthalmology, Institute of Ophthalmology, “Conde de Valenciana”, Mexico City. “In our own series of 19 eyes with a mean follow-up of 8 months, patients achieved significant improvement in SE with significant decreases in both sphere and astigmatism.

“However, there are a few important criteria to consider, and patients must be counseled that a risk of progression of keratoconus persists,” he added. “Nevertheless, if the refractive changes are mild or even if refractive surprises occur after the surgery, vision can be corrected with spectacles or contacts.”

Discussing selection criteria, Dr. Navas said toric IOLs should be avoided in patients with central cornea scars, if they have unstable or progressive keratoconus, and if refraction cannot be performed.

In addition, the patient must have a topographically identifiable axis to align the toric IOL properly, and the astigmatism should be “not so irregular.” For the latter reason, Dr. Navas said he initially considered only eyes with mild keratoconus and excludes eyes with advanced disease.

Providing some additional recommendations, Dr. Navas suggested using an age cut-off of <48 years for implanting a phakic IOL and considering refractive lens exchange as a more suitable option in patients older than 55 years. However, he noted these criteria are debatable and that the reversibility of a phakic IOL versus irreversibility of an in-the-bag IOL might also be considered.

For power calculation when implanting a pseudophakic IOL, Dr. Navas recommended the use of keratometry obtained by topography and/or tomography, interferometry for axial length measurement, and the SRK II formula, which, according to the literature, may cover a broader spectrum of cases.

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.